Statements (17)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:pegfilgrastim-cbqv
|
| gptkbp:approvalYear |
2018-11-02
|
| gptkbp:ATCCode |
L03AA13
|
| gptkbp:biosimilar |
gptkb:Neulasta
|
| gptkbp:brand |
gptkb:UDENYCA
|
| gptkbp:countryOfOperation |
gptkb:United_States
|
| gptkbp:drugClass |
colony stimulating factor
|
| gptkbp:form |
injection
|
| gptkbp:genericName |
gptkb:pegfilgrastim-cbqv
|
| https://www.w3.org/2000/01/rdf-schema#label |
UDENYCA
|
| gptkbp:indication |
reduce the incidence of infection, as manifested by febrile neutropenia, in patients with non-myeloid malignancies receiving myelosuppressive anti-cancer drugs
|
| gptkbp:manufacturer |
gptkb:Coherus_BioSciences
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:routeOfAdministration |
subcutaneous injection
|
| gptkbp:bfsParent |
gptkb:Coherus_BioSciences
|
| gptkbp:bfsLayer |
7
|